Immunocore Holdings plc IMCR
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Sean Laaman | Morgan Stanley | 34.5325 $ | 36 $ | 1.47 % | 10/11/2025 |
| Eva Fortea Verdejo | Wells Fargo | 32.19 $ | 60 $ | 27.81 % | 31/10/2025 |
| David Dai | UBS | 32.02 $ | 24 $ | -8.02 % | 24/10/2024 |
| Justin Kim | Oppenheimer | 33.05 $ | 89 $ | 55.95 % | 16/09/2024 |
| Graig Suvannavejh | Mizuho Securities | 33.44 $ | 72 $ | 38.56 % | 12/09/2024 |
| Patrick Trucchio | H.C. Wainwright | 35.71 $ | 100 $ | 64.29 % | 28/08/2024 |
| Peter Lawson | Barclays | 37.92 $ | 66 $ | 28.08 % | 09/08/2024 |
| Graig Suvannavejh | Mizuho Securities | 57.25 $ | 88 $ | 30.75 % | 13/05/2024 |
| Bill Maughan | Canaccord Genuity | 61.32 $ | 67 $ | 5.68 % | 09/05/2024 |
| Rajan Sharma | Goldman Sachs | 59.42 $ | 80 $ | 20.58 % | 15/12/2022 |
| Michael Yee | Jefferies | 44.0339 $ | 68 $ | 23.97 % | 09/09/2022 |